Under this agreement, Cipla has exclusive rights to market the innovative treatment for post-operative inflammation and pain ...

Formosa Smart underscores its ambitions to position Taiwan as a regional battery hub. Chairman Sandy Wang called the facility ...

Cipla has announced an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals to market clobetasol ...

Taiwan identified 2027 as the potential year for a Chinese invasion for the first time in its annual military drills, as ...

Under this agreement, Cipla has exclusive rights to market the innovative treatment for post-operative inflammation and pain ...

Drug maker Cipla on Tuesday said it has inked an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals for the commercialisation of clobetasol propionate ophthalmic suspension. As ...

In a strategic shift reflecting growing geopolitical concerns, Taiwanese companies are gaining unprecedented governmental ...

Cipla's ophthalmology division is focused on developing therapies and technologies for glaucoma, dry eye disease, ocular infections and retinal diseases. The strategic licensing agreement with Formosa ...

It’s unclear how the 2027 setting will change the programme, or if the date is more a political signal. Read more at ...

The exercises will also double in length to ten days this summer, reflecting an increased emphasis on military preparedness ...